[HTML][HTML] Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
G Li, X Yan - Journal of Orthopaedic Surgery and Research, 2023 - Springer
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
[HTML][HTML] Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
G Li, X Yan - Journal of Orthopaedic Surgery and …, 2023 - josr-online.biomedcentral.com
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis.
G Li, X Yan - Journal of Orthopaedic Surgery and Research, 2023 - europepmc.org
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
[HTML][HTML] Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
G Li, X Yan - Journal of Orthopaedic Surgery and Research, 2023 - ncbi.nlm.nih.gov
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
G Li, Y Xue - Journal of Orthopaedic Surgery and Research, 2023 - search.proquest.com
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis.
G Li, X Yan - Journal of Orthopaedic Surgery & Research, 2023 - search.ebscohost.com
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
G Li, X Yan - Journal of orthopaedic surgery and research, 2023 - pubmed.ncbi.nlm.nih.gov
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
[PDF][PDF] Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
G Li, X Yan - Journal of Orthopaedic Surgery and …, 2023 - josr-online.biomedcentral.com
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis.
G Li, X Yan - Journal of Orthopaedic Surgery and Research, 2023 - europepmc.org
Osteosarcoma is a common malignant bone tumor. Cisplatin (DDP) achieves a high
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …
response rate in osteosarcoma. Here we aim to study the dysregulation of long non-coding …